Cortney Bernardo, PA
Medical · St George, UTNPI 1285735688
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,361 of the $8,209 with a category attached, or 65.3%. 26 manufacturers reported payments, led by Boston Scientific at 45.4% of the total. Reporting peaked in 2021 at $4,384 and has fallen 82.4% since, to $770 in 2025. Among medical clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 256 payments — averaging $32.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Biohaven Pharmaceuticals, Inc.$1K
- AbbVie$967
- Nevro Corp.$344
- Medtronic$342
- Pfizer$326
- plus $1K from 20 others
What the payments were for
- Consulting fees$80010%
- Travel & lodging$2,04925%
- Food & beverage$5,36165%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 60 | $3,727 |
| Biohaven Pharmaceuticals, Inc. | 9 | $1,024 |
| AbbVie(2 entities) | 51 | $967 |
| Nevro Corp. | 11 | $344 |
| Medtronic | 17 | $342 |
| Pfizer | 19 | $326 |
| Lundbeck LLC | 9 | $156 |
| Nalu Medical, Inc. | 6 | $145 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $143 |
| Abbott | 17 | $131 |
| Teva Pharmaceuticals USA, Inc. | 6 | $113 |
| Relievant Medsystems, Inc. | 5 | $85 |
| SPR Therapeutics, Inc | 6 | $84 |
| GRT US Holding, Inc. | 5 | $84 |
| Averitas Pharma Inc. | 3 | $83 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $77 |
| Redhill Biopharma Inc. | 4 | $75 |
| Amgen | 4 | $70 |
| Vertos Medical, Inc. | 1 | $59 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Radius Health, Inc. | 2 | $34 |
| Lilly USA, LLC | 2 | $32 |
| Bioventus LLC | 1 | $23 |
| Protega Pharmaceutials Inc | 1 | $20 |
| Vertex | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WAVEWRITER ALPHA$2,444
- NURTEC ODT$948
How this compares
$8,209 in reported general payments places this provider in the 90th percentile of 263 medical providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 27 | $31,046 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 873 | $28,812 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 522 | $23,834 |
| Oxycodone Hcl | 619 | $16,501 |
| Fentanyl | 174 | $15,609 |
| Aimovig AutoinjectorErenumab-Aooe | 12 | $15,148 |
| MovantikNaloxegol Oxalate | 32 | $14,188 |
| Morphine Sulfate ErMorphine Sulfate | 440 | $10,485 |
| BelbucaBuprenorphine Hcl | 12 | $10,290 |
| Nucynta ErTapentadol Hcl | 12 | $7,224 |
| Oxymorphone Hcl ErOxymorphone Hcl | 12 | $6,904 |
| Gabapentin | 298 | $5,405 |
| Buprenorphine | 15 | $4,125 |
| Morphine Sulfate | 110 | $3,961 |
| Tramadol Hcl | 153 | $3,453 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $326 | $31,04627 claims |
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta Er | $35 | $17,51424 claims |
| Redhill Biopharma Inc.Movantik | $75 | $14,18832 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 263 medical providers in Utah.
Other medical in St George
- Mark UdySt George$9K
- Hayden WorwoodSt George$9K
- Brian JorgensenSt George$7K
- Louis DuranteSt George$4K
- Joshua WilliamsSt George$4K
- Nicholas DemilleSt George$3K
- Elisa WilcoxSalt Lake City$178K
- Val WarnerLayton$51K
- Viet leSalt Lake City$42K
- Carmelo DiazSalt Lake City$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.